Company Summary - Deltex Medical Group PLC (LSE:DEMG)
13.25p
0.50p
(-3.64%)
FTSE AIM All Share Health Care Equipment & ServicesMarket cap: £16.816m
Review a company's summary page in more detail and see the key fundamentals at a glance. Sign-up to Premium now to make your investment decisions.
Sign-up to Premium's Free 7 Day trial See an improved company summary
Summary
Manufacture & marketing of oesophageal Doppler haemodynamic monitoring systems
| Financials - Prelim (16/3/2010) | ||
|---|---|---|
| Turnover | £m | 5.64 |
| Pre-tax Profit | £m | -2.13 |
| EPS | p | -1.37 |
| DPS | p | 0.00 |
| Director | Board Role |
|---|---|
| Nigel Keen | Chairman |
| Ewan Phillips | Chief Executive |
| Paul Mitchell | Finance Director & Company Sec |
Products Brands & Subsidiaries
Products & Brands
CardioQ; NeuroQ; SupraQ
Subsidiaries
Deltex Medical Ltd; Deltex Medical, Espana; Deltex Medical, GmbH; Deltex Medical SC, Inc
Broker Sentiment (2 brokers)
Strong SellStrong Buy
| Heading | Date |
|---|---|
| Preliminary Results | 16/03/2010 |
| Results of NHS Study | 14/01/2010 |
| Pre-Close Update | 13/01/2010 |